Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions

American Journal of Cardiology

Volumn 113, Issue 11, 2014, Pages 1834-1838

  Bavishi, Chirag ^a   Ather, Sameer ^b   Bambhroliya, Arvind ^c   Jneid, Hani ^c,d   Virani, Salim S ^c,d   Bozkurt, Biykem ^c,d   Deswal, Anita ^c,d  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SODIUM; SPIRONOLACTONE;

AFRICAN AMERICAN; AGED; ANEMIA; ARTICLE; BODY MASS; COHORT ANALYSIS; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART FAILURE WITH REDUCED EJECTION FRACTION; HOSPITALIZATION; HUMAN; HYPONATREMIA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; SODIUM BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; VETERAN;

AGED; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITALIZATION; HUMANS; HYPONATREMIA; INCIDENCE; MALE; OUTPATIENTS; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SODIUM; STROKE VOLUME; SURVIVAL RATE; TIME FACTORS; UNITED STATES; VENTRICULAR FUNCTION, LEFT; VETERANS;

EID: 84900875462     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2014.03.017     Document Type: Article

References (15)

1. H.J. Adrogue, and N.E. Madias Hyponatremia N Engl J Med 342 2000 1581 1589
2. L. De Luca, L. Klein, J.E. Udelson, C. Orlandi, G. Sardella, F. Fedele, and M. Gheorghiade Hyponatremia in patients with heart failure Am J Cardiol 96 2005 19L 23L
3. L. Bettari, M. Fiuzat, G.M. Felker, and C.M. O'Connor Significance of hyponatremia in heart failure Heart Fail Rev 17 2012 17 26
4. D. Rusinaru, C. Tribouilloy, C. Berry, A.M. Richards, G.A. Whalley, N. Earle, K.K. Poppe, M. Guazzi, S.M. Macin, M. Komajda, R.N. Doughty, and Investigators M Relationship of serum sodium concentration to mortality in a wide spectrum of heart failure patients with preserved and with reduced ejection fraction: an individual patient data meta-analysis (dagger): meta-analysis global group in chronic heart failure (MAGGIC) Eur J Heart Fail 14 2012 1139 1146
5. A. Deswal, N.J. Petersen, D.L. Urbauer, S.M. Wright, and R. Beyth Racial variations in quality of care and outcomes in an ambulatory heart failure cohort Am Heart J 152 2006 348 354
6. S. Ather, W. Chan, B. Bozkurt, D. Aguilar, K. Ramasubbu, A.A. Zachariah, X.H. Wehrens, and A. Deswal Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction J Am Coll Cardiol 59 2012 998 1005
7. A.S. Levey, J. Coresh, T. Greene, L.A. Stevens, Y.L. Zhang, S. Hendriksen, J.W. Kusek, F. Van Lente, and Chronic Kidney Disease Epidemiology C Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate Ann Intern Med 145 2006 247 254
8. L. Bettari, M. Fiuzat, L.K. Shaw, D.M. Wojdyla, M. Metra, G.M. Felker, and C.M. O'Connor Hyponatremia and long-term outcomes in chronic heart failure - an observational study from the Duke Databank for cardiovascular diseases J Card Fail 18 2012 74 81
9. A. DeWolfe, B. Lopez, L.M. Arcement, and K. Hebert Low serum sodium as a poor prognostic indicator for mortality in congestive heart failure patients Clin Cardiol 33 2010 E13 E17
10. L. Balling, M. Schou, L. Videbaek, P. Hildebrandt, H. Wiggers, F. Gustafsson, and Danish Heart Failure Clinics N Prevalence and prognostic significance of hyponatraemia in outpatients with chronic heart failure Eur J Heart Fail 13 2011 968 973
11. D. Rusinaru, O. Buiciuc, L. Leborgne, M. Slama, Z. Massy, and C. Tribouilloy Relation of serum sodium level to long-term outcome after a first hospitalization for heart failure with preserved ejection fraction Am J Cardiol 103 2009 405 410
12. L. Klein, C.M. O'Connor, J.D. Leimberger, W. Gattis-Stough, I.L. Pina, G.M. Felker, K.F. Adams Jr., R.M. Califf, M. Gheorghiade, and Investigators O-C Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study Circulation 111 2005 2454 2460
13. M. Gheorghiade, W.A. Gattis, C.M. O'Connor, K.F. Adams Jr., U. Elkayam, A. Barbagelata, J.K. Ghali, R.L. Benza, F.A. McGrew, M. Klapholz, J. Ouyang, C. Orlandi, and Acute, Chronic Therapeutic Impact of a Vasopressin Antagonist in Congestive Heart Failure I Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial JAMA 291 2004 1963 1971
14. N. Deubner, D. Berliner, A. Frey, G. Guder, S. Brenner, W. Fenske, B. Allolio, G. Ertl, C.E. Angermann, and S. Stork Dysnatraemia in heart failure Eur J Heart Fail 14 2012 1147 1154
15. M.A. Konstam, M. Gheorghiade, J.C. Burnett Jr., L. Grinfeld, A.P. Maggioni, K. Swedberg, J.E. Udelson, F. Zannad, T. Cook, J. Ouyang, C. Zimmer, C. Orlandi, and Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan I Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial JAMA 297 2007 1319 1331